Mode
Text Size
Log in / Sign up

Acute Respiratory Distress Syndrome

Subtypes of Acute Respiratory Distress Syndrome

Acute Lung Injury 4 Hyaline membrane disease 1 Neonatal respiratory distress syndrome 1 Preterm Infant Respiratory Distress 0

24 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Acute Respiratory Distress Syndrome

67 trials tracked for Acute Respiratory Distress Syndrome: 12 in phase 3 or 4 and 10 with published results. The most-cited published study has 1406 citations.

67Trials tracked
12Phase 3 & 4
0Recruiting
10With published results
Phase distribution
Phase 4 1 Phase 3 11 Phase 2 23 Phase 1 3 Other / NA 29
  1. Phase 3 Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 Completed · 1,406 cited
  2. Phase 3 Reevaluation Of Systemic Early Neuromuscular Blockade Completed · 876 cited
  3. Phase 3 Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial Completed · 813 cited
  4. Phase 3 Vitamin D to Improve Outcomes by Leveraging Early Treatment Completed · 301 cited
  5. Phase 3 Pre-exposure Prophylaxis for SARS-Coronavirus-2 Completed · 128 cited
  6. Phase 3 Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients Completed · 91 cited
Show 44 more trials
  1. Phase 3 Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Completed · 75 cited
  2. Phase 3 Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure Completed · 27 cited
  3. Phase 3 A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants Completed · 19 cited
  4. Phase 3 A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 Completed · 3 cited
  5. Phase 4 Premedication for Non-Emergency Endotracheal Intubation In the NICU Completed
  6. Phase 3 Nitric Oxide Administration for Acute Respiratory Distress Syndrome Completed
  7. Phase 2 Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates Completed
  8. Phase 2 Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury Completed
  9. Phase 2 Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection Completed
  10. Phase 2 Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) Completed
  11. Phase 2 Extracorporeal Membrane Oxygenation (ECMO) in Non-intubated Patients With Acute Respiratory Distress Syndrome (ARDS) Completed
  12. Phase 2 Losartan for Patients With COVID-19 Requiring Hospitalization Completed
  13. Phase 2 LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Completed
  14. Phase 2 Tenecteplase in Patients With COVID-19 Completed
  15. Phase 2 LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) Completed
  16. Phase 2 Efficacy and Safety of Itolizumab in COVID-19 Complications Completed
  17. Phase 2 The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age Completed
  18. Phase 2 Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II Completed
  19. Phase 2 Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS Completed
  20. Phase 2 A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 Completed
  21. Phase 2 Losartan for Patients With COVID-19 Not Requiring Hospitalization Completed
  22. Phase 2 Use of UC-MSCs for COVID-19 Patients Completed
  23. Phase 2 Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Completed
  24. Phase 2 Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) Completed
  25. Phase 2 LIPS-A: Lung Injury Prevention Study With Aspirin Completed
  26. Phase 2 Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure Completed
  27. Phase 2 A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI) Completed
  28. Phase 2 Acetaminophen and Ascorbate in Sepsis: Targeted Therapy to Enhance Recovery Completed
  29. Phase 2 Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS Completed
  30. Phase 1 Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome Completed
  31. Phase 1 Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Completed
  32. Phase 1 Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome Completed
  33. N/A Restore Resilience in Critically Ill Children Completed
  34. N/A A Study Promoting Critical Illness Recovery in the Elderly Completed
  35. N/A Ventilator-induced Lung Injury Vortex in Patients With SARS-CoV-2 Completed
  36. N/A Comparative Effectiveness Study of Bubble CPAP Devices in the NICU Completed
  37. N/A Prehospital Telemedicine Feasibility/Acceptability Pilot Completed
  38. N/A Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS Completed
  39. N/A The Role of Circulating Soluble CD74 in Acute Lung Injury Completed
  40. N/A A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation Completed
  41. N/A Retrospective Review of Mechanically Ventilated Patients Using a Continuous Data Collection System. Completed
  42. N/A ED Lung Protective Ventilation to Reduce Complications Completed
  43. N/A Implementation of Nudges to Promote Utilization of Low Tidal Volume Ventilation (INPUT) Study Completed
  44. N/A Trial of Non Invasive Ventilation for Respiratoy Distress Syndrome Completed

Showing the 50 most-cited and recently-updated of 67 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Acute Respiratory Distress Syndrome

Is prone positioning recommended for adults with moderate-to-severe COVID-19 ARDS?

Yes, prone positioning is recommended for adults with moderate-to-severe COVID-19 ARDS, especially when receiving mechanical ventilation, as it improves oxygenation and may reduce mortality.

Full answer →
Can artificial intelligence help treat patients in the intensive care unit?

Yes, AI shows promise in ICU care for tasks like ARDS subphenotyping, ventilator synchrony, and imaging analysis, but real-world use remains limited by data quality and implementation challenges.

Full answer →
Can nasal high-flow oxygen replace CPAP for primary respiratory support in babies with respiratory distress syndrome?

Nasal high-flow oxygen cannot replace CPAP for primary respiratory support in babies with respiratory distress syndrome because clinical trials show it leads to significantly higher treatment failure rates compared to CPAP.

Full answer →
Are LISA and ENSURE treatments equally good for preterm babies with respiratory distress syndrome?

Research shows that LISA and ENSURE are equally good at reducing the need for mechanical ventilation in preterm babies with respiratory distress syndrome.

Full answer →
What are the mortality effects of prone positioning for COVID-19 Acute Respiratory Distress Syndrome?

Prone positioning for COVID-19 ARDS improves oxygenation and may reduce mortality, especially with extended sessions (>24 h), but increases pressure injury risk.

Full answer →
Does prolonged prone positioning improve oxygenation for Acute Respiratory Distress Syndrome?

Yes, prolonged prone positioning (≥24 hours) improves oxygenation in ARDS, but its effect on mortality is uncertain and it increases pressure injury risk.

Full answer →
Can lung ultrasound accurately diagnose Acute Respiratory Distress Syndrome?

Yes, lung ultrasound is a reliable, non-invasive tool for diagnosing ARDS, with high specificity (87%) and good sensitivity (75%) according to a large meta-analysis.

Full answer →
See all 7 questions about Acute Respiratory Distress Syndrome →

All Acute Respiratory Distress Syndrome Articles